Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
July 12
 · 
Be the first to react
A MyMyelomaTeam Member

I know a few people with light chain and they are all doing well and past 5 years since diagnosis.

July 20
A MyMyelomaTeam Member

I would have thought that remission means fewer or no mutations and less or no calcium being filtered by the kidneys. If so, the number of patients surviving past the 2 and 3 year milestones should have increased.

July 12 (edited)
MyMyelomaTeam

Great question, and it's one worth unpacking carefully. For myeloma overall, the five-year survival rate sits around 61 percent. For light chain myeloma specifically, survival tends to be somewhat shorter — potentially by up to two years — largely because light chains can cause kidney damage, which complicates treatment Show Full Answer

Great question, and it's one worth unpacking carefully. For myeloma overall, the five-year survival rate sits around 61 percent. For light chain myeloma specifically, survival tends to be somewhat shorter — potentially by up to two years — largely because light chains can cause kidney damage, which complicates treatment. That said, the picture is genuinely improving. Here's what's worth knowing:

- The five-year survival rate for myeloma has doubled over the past 30 years
- Newer monoclonal antibody drugs have added years to life expectancy
- Maintenance therapy after stem cell transplant is now standard care and is keeping people in remission longer
- Survival statistics are based on data from at least five years ago, so they don't yet reflect the most recent treatment advances It's also important to remember that statistics describe groups of people, not individuals. Factors like kidney function, genetics, and access to specialist care all play a role in personal outcomes.

Having an open conversation with an oncologist who specializes in myeloma is the best way to understand what the current numbers mean for a specific situation.

July 12

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Kingwood, TX

A MyMyelomaTeam Member asked a question 💭
Myrtle Beach, SC